Pithy intro text about the biopharma milieu.  Novartis cites more tumor reports after Zolgensma Novartis has disclosed seven previously unreported cases of tumors in children who received Zolgensma, its gene therapy…
Pithy intro text about the biopharma milieu.  Novartis cites more tumor reports after Zolgensma Novartis has disclosed seven previously unreported cases of tumors in children who received Zolgensma, its gene therapy…
<iframe src="https://statesidedaily.com/embed/cluster/6ab4846a3345aa528921bcc12d8b993ce01cff2a" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Amgen’s Repatha linked to fewer heart attacks"></iframe>
